|
|
|
Volumn 14, Issue 6 SUPPL. 2, 2000, Pages 31-35
|
|
Combination therapy with purine nucleoside analogs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CORDYCEPIN;
DEOXYADENOSINE DERIVATIVE;
DRUG DERIVATIVE;
FLUDARABINE;
INTERFERON;
PENTOSTATIN;
PURINE NUCLEOSIDE;
VIDARABINE;
ADULT;
AGED;
B CELL LYMPHOMA;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DOSE RESPONSE;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
REVIEW;
T CELL LYMPHOMA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
DEOXYADENOSINES;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
INTERFERONS;
LYMPHOMA, B-CELL;
LYMPHOMA, T-CELL;
MALE;
MIDDLE AGED;
PENTOSTATIN;
PURINE NUCLEOSIDES;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 0034200599
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (25)
|
|
References (4)
|
